Impact of high dose of baricitinib in severe COVID-19 pneumonia: a prospective cohort study in Bangladesh

Impact of high dose of baricitinib in severe COVID-19 pneumonia: a prospective cohort study in Bangladesh

Abstract Purpose Hyperinflammation in severe COVID-19 infection increases the risk of respiratory failure and one of the cogent reasons of mortality associated with COVID-19. Baricitinib, a janus kinases inhibitor, can potentially suppress inflammatory cascades in severe COVID-19 pneumonia. Methods...

Full description

Bibliographic Details
Main Authors: Md. Jahidul Hasan, Raihan Rabbani, Ahmad Mursel Anam, Shihan Mahmud Redwanul Huq, Mohammad Mufizul Islam Polash, Shahzadi Sayeeda Tun Nessa, Sitesh C. Bachar
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Infectious Diseases
Subjects:
Baricitinib
Severe COVID-19 pneumonia
Cytokine storm
High dose
Usual dose
Online Access:https://doi.org/10.1186/s12879-021-06119-2

Internet

https://doi.org/10.1186/s12879-021-06119-2

Similar Items